MD Medical Group Investments Plc (MDMG)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 1,306.80 |
|---|---|
| 52-week range | 1,050.00 – 1,559.10 |
| Return, 1 month / 3 months | +0.1% / +13.0% |
| Return, 1 year / 3 years | +6.1% / +54.6% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 23.5% |
| Worst drawdown (1 year) | -31.5% |
| Average daily value traded | 123.53M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MD Medical Group Investments runs a network of private medical clinics in Russia, operating mainly under the Mother and Child name. The clinics provide obstetric, gynaecological and fertility care, together with paediatric and general medical services for families and individual patients. The group is based in Moscow and serves patients through its own hospitals and outpatient centres across several Russian cities.
MD Medical Group Investments Plc trades under the code MDMG on the Moscow Exchange in Russia, with its price quoted in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MD Medical Group Investments Plc (MDMG) trades on the Moscow Exchange in Russia. It last closed at RUB 1,306.80 on 19 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 15 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.1% and over the last three months it rose 13.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -2.6% | ||
| From 52-week high | -15.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.0% | ||
| 6-month return | -4.9% | ||
| 12-month return, skipping the last month | 6.0% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.5% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 123.53M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +0.1% |
| 3 months | +13.0% |
| 6 months | −4.9% |
| 1 year | +6.1% |
| 3 years | +54.6% |
| 5 years | +59.1% |
Signals
| 50-day / 200-day average | 1,305.77 / 1,342.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 28.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2024 | RUB 15.1800 |
| 7 Nov 2023 | RUB 21.6900 |
| 11 Sep 2023 | RUB 15.1800 |
| 11 Jul 2023 | RUB 23.4900 |
| 5 Jun 2023 | RUB 23.4900 |
| 5 May 2023 | RUB 23.4900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.